Oswaldo Aguilar | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Oswaldo Aguilar | Medicine and Dentistry | Best Researcher Award

Dr Oswaldo Aguilar, Universidad del Valle, Colombia

Dr. Oswaldo Aguilar 🩺❤️ is a cardiologist and echocardiography specialist at Hospital Universitario del Valle, Colombia. He also serves as a lecturer at Universidad del Valle and Universidad Libre. Dr. Aguilar holds a medical degree from Universidad Rafael Núñez and specialized in Internal Medicine and Clinical Cardiology. A prolific author, he has contributed to key medical textbooks and journals 📚. He is a member of the American College of Physicians, the Sociedad Colombiana de Cardiología, and ESC. Passionate about cardiovascular imaging and heart failure research, Dr. Aguilar actively shapes future medical professionals through teaching and mentorship. 🎓💉

Publication Profile

Scopus

Clinical Expertise and Teaching

Dr. Oswaldo Aguilar is a dedicated cardiologist and medical educator 🩺❤️. Since January 2024, he has worked at Hospital Universitario del Valle in advanced cardiac imaging. He also teaches postgraduate internal medicine and cardiology at Universidad del Valle and Universidad Libre, Cali 👨‍🏫. Dr. Aguilar has been a cardiologist at Colsanitas S.A. since 2022. Previously, he completed a cardiology fellowship at Universidad de Antioquia and practiced internal medicine at Hospital Universitario del Valle and Fundación Valle de Lili 🏥. His experience spans urgent care, hospital wards, and intensive care, showcasing his commitment to patient care and medical training.

Complementaria

Dr. Oswaldo Aguilar is a dedicated cardiologist with advanced training in cardiovascular imaging and clinical care ❤️‍🩹. He completed an ultrasound program for major syndromes at Universidad Cardenal Herrera (2019-2020) and holds diplomas in cardiovascular medicine 🫀 and clinical research 📊. His expertise spans heart failure management, anticoagulation, and pulmonary hypertension. He has extensive hands-on training, including a 2024 rotation in advanced cardiac imaging at Hospital Clínico San Carlos, Madrid 🏥. Certified in ACLS and trauma care, Dr. Aguilar is a Fellow in Training with the ACC (2020-2023) and proficient in POCUS imaging techniques 📈.

Recognition and Affiliations

Dr. Oswaldo Aguilar is a distinguished cardiologist with memberships in prestigious organizations, including the American College of Physicians 🩺, Sociedad Colombiana de Cardiología ❤️, and the European Society of Cardiology (ESC) 🌍. His affiliations reflect his dedication to advancing cardiovascular medicine and active participation in global cardiology networks. Dr. Aguilar’s involvement in these esteemed societies highlights his commitment to staying at the forefront of medical research and innovation, fostering collaboration with experts worldwide. Through these connections, he continually enhances his expertise, contributing to improved patient care and shaping the future of cardiology.

Research Focus

Dr. Oswaldo Aguilar’s research focuses on cardiovascular health 🫀, particularly in echocardiographic findings, aortic stenosis, heart failure, and coronary artery disease. His studies analyze systemic lupus erythematosus patients, mortality predictors, and atrial fibrillation treatments. Dr. Aguilar’s work spans retrospective cohort studies and practical reviews, emphasizing real-world applications in cardiology clinics and emergency rooms 🏥. His publications address critical issues like prosthetic valve thrombosis, aiming to improve patient outcomes through advanced diagnostic and therapeutic strategies. Dr. Aguilar’s contributions reflect a dedication to enhancing cardiovascular care and advancing knowledge in cardiology 📚❤️.

Publication Top Notes

Echocardiographic findings in patients with systemic lupus erythematosus: Retrospective analysis in a tertiary referral centre | Hallazgos ecocardiográficos en pacientes con lupus eritematoso sistémico: análisis retrospectivo en un centro de referencia terciaria

Low-Flow, Low-Gradient Severe Aortic Stenosis in patients with preserved or reduced ejection fraction: a systematic literature review.

Application of eligibility criteria from DAPA-HF, EMPEROR-Reduced, and PARADIGM-HF trials to a population with heart failure with reduced ejection fraction at a specialized cardiology Clinic in Medellin, Colombia: A retrospective cohort study

Atrial fibrillation treatment in the emergency room: a practical narrative review | Tratamiento de la fibrilación auricular en el servicio de urgencias: una revisión práctica de la literatura

Predictors of mortality in patients with coronary artery disease and involvement of the left main artery | Factores predictores de mortalidad en pacientes con enfermedad coronaria y compromiso del tronco principal izquierdo

Prosthetic valve thrombosis and thrombolytic therapy in the modern era: a case report | Trombosis valvular y terapia trombolítica en la era moderna: reporte de un caso

 

Fatmah Alasmary | Pharmaceutical innovation | Best Researcher Award

Posted on by ScienceFather

Prof. Fatmah Alasmary | Pharmaceutical innovation | Best Researcher Award

Prof. Fatmah Alasmary, Saudi Food and Drug Authority, Saudi Arabia

Professor at King Saud University, specializing in organic chemistry. Dr. Alasmary has extensive experience in academia and leadership, with a PhD from the University of Bradford. Currently, she serves as Director of the Drug Lab at the Saudi Food and Drug Authority. Her research interests include antimicrobial agents and nanomaterials. Dr. Alasmary has mentored numerous students and has held key roles in various scientific committees. She is a member of the Saudi Chemical Association, the Royal Society of Chemistry, and the American Chemical Society. 🧑‍🔬👩‍🏫🔬

Publication Profile

Google Scholar

Work Experience 🌍💼

Prof. Fatmahalasmary is a distinguished academic and professional, currently serving as the Director of Drug Lab at Saudi Food and Drug Authority, Riyadh. She oversees quality control, safety standards, and international accreditation efforts for medicines and cosmetics. As Chief of Senior Expert International Communication, she leads food standards initiatives for Saudi Arabia, managing ISO committees and Codex committees. Previously, she was Vice Chairman at King Saud University’s Chemistry Department, coordinating research, teaching, and international collaborations. Prof. Fatmahalasmary’s leadership spans teaching, curriculum development, and guiding postgraduate research, exemplifying excellence in both academic and professional spheres. 📚🌐👩‍🔬

 

Qualifications 🎓🌟

Prof. Fatmahalasmary holds a PhD in Chemistry from the University of Bradford, England (2013), where her thesis focused on the synthesis and evaluation of benzimidazole derivatives as potential antimicrobial agents. She earned a Master of Science in Chemistry from King Saud University, KSA (2008), with a thesis on the synthesis and study of quinoxaline derivatives. Additionally, she completed her Bachelor of Science in Chemistry at King Saud University, KSA (2001), graduating with honors. Her academic journey highlights a strong foundation in chemistry and a commitment to research excellence. 🧪📘👩‍🔬

 

Additional Experience 🌍🔬

Prof. Fatmahalasmary has actively participated in over 22 workshops focused on management, planning, and quality development. She is a member of several prestigious associations, including the Saudi Chemical Association, Royal Society of Chemistry, and American Chemical Society. Her roles have included coordinating committees at King Saud University (KSU), such as the Development and Quality Committee and Labs Committee. Prof. Fatmahalasmary has also been involved in thesis defenses, scientific symposia, and national exhibitions. She holds patents for innovative extracts and is certified in ISO 9001:2015 and as a Certified Innovation Professional. 📚💡📈

 

Research Focus

Prof. Fatmah Ali S Alasmary’s research spans various fields, including antimicrobial agents 🦠, biological chemistry 🧬, and medicinal chemistry 💊. She has contributed significantly to the development of benzimidazole derivatives as potential antimicrobial agents, as well as carbonic anhydrase inhibitors targeting various pathogens. Her work also delves into perovskite materials 🏗️, photocatalysis ⚛️, and nanomaterials 🧪 with applications in sensing and biomedical fields. Prof. Alasmary has been actively involved in computational studies of drug design 💻, enzyme inhibition 🧪, and therapeutic applications for diseases like malaria and cancer.

 

Publication Top Notes  

  • Tin versus lead redox chemistry modulates charge trapping and self-doping in tin/lead iodide perovskites (186 citations, 2020) 🔋
  • Synthesis and evaluation of selected benzimidazole derivatives as potential antimicrobial agents (140 citations, 2015) 💊
  • Inhibition of the β-carbonic anhydrase from the dandruff-producing fungus Malassezia globosa with monothiocarbamates (41 citations, 2017) 🦠
  • Direct Access to α‐Aminosilanes Enabled by Visible‐Light‐Mediated Multicomponent Radical Cross‐Coupling (36 citations, 2021) 💡
  • Development of certain novel N-(2-(2-(2-oxoindolin-3-ylidene)hydrazinecarbonyl)phenyl)-benzamides and 3-(2-oxoindolin-3-ylideneamino)-2-substituted quinazolin-4(3 H)-ones as … (35 citations, 2015) 🔬
  • Analysis of Alpina officinarum Hance, chemically and biologically (30 citations, 2019) 🌿
  • Combined computational and experimental investigation on the nature of hydrated iodoplumbate complexes: Insights into the dual role of water in perovskite precursor solutions (28 citations, 2020) 💧
  • The first activation studies of the η-carbonic anhydrase from the malaria parasite Plasmodium falciparum with amines and amino acids (28 citations, 2018) 🦠
  • New quinoxalinone inhibitors targeting secreted phospholipase A2 and α-glucosidase (28 citations, 2017) 🧪
  • Structure-based identification of SARS-CoV-2 main protease inhibitors from anti-viral specific chemical libraries: an exhaustive computational screening approach (27 citations, 2021) 🦠

 

Chun-Feng Huang | Health Professions | Best Researcher Award

Posted on by ScienceFather

Assist. Prof. Dr. Chun-Feng Huang | Health Professions | Best Researcher Award

Chief of Family Medicine at En Chu Kong Hospital/National Yang Ming Chiao Tung University, Taiwan

Dr. Chun-Feng Huang is an Assistant Professor at the National Yang Ming Chiao Tung University and the Chief of Family Medicine at En Chu Kong Hospital. With a rich academic background, including a Ph.D. from Taipei Medical University and an MD from National Yang Ming Chiao Tung University, Dr. Huang is a certified expert in Family Medicine, Hospice and Palliative Medicine, and Osteoporosis. His research spans metabolomics, precision medicine, gerontology, and osteoporosis, with numerous publications in reputable journals. 🌊🔬.

Publication Profile

Education

Dr. Chun-Feng Huang earned his Doctor of Medicine degree from the National Yang Ming Chiao Tung University, School of Medicine, Taiwan. He further specialized by obtaining a Ph.D. from Taipei Medical University’s Graduate Institute of Clinical Medicine. Complementing his advanced education, Dr. Huang holds various board certifications: Family Medicine, Hospice and Palliative Medicine, Integrative Medicine, and Osteoporosis. Additionally, he is a Certified Clinical Densitometrist accredited by the International Society for Clinical Densitometry (ISCD). His academic journey reflects a deep commitment to continuous learning and specialization in both clinical and research domains, equipping him with a robust foundation to tackle complex medical challenges. Dr. Huang’s educational background not only highlights his expertise in medicine but also underscores his dedication to advancing patient care through education, research, and clinical excellence.

Experience

Dr. Chun-Feng Huang’s career is marked by influential roles in academia and clinical practice. He currently serves as an Assistant Professor at the National Yang Ming Chiao Tung University and Chief of the Department of Family Medicine at En Chu Kong Hospital. Previously, he directed the Department of Family Medicine at the same university hospital from 2016 to 2022. His leadership extended to chairing healthcare services for correctional institutions and community development associations. As Deputy Secretary General and former Prevention Committee Deputy Chairman of the Taiwan Association of Family Medicine, Dr. Huang has shaped national health policies. He also contributed as a Director for the Taipei Smart City IoT Association. His experience in reviewing medical policies for Taiwan’s FDA and involvement in mountain healthcare projects demonstrates his dedication to improving public health systems and addressing diverse healthcare needs through integrated solutions.

Awards and Honors

Dr. Chun-Feng Huang has received numerous accolades for his contributions to medicine and community health. He was recognized with the First Prize at the Annual Academic Conference by the Taiwan Association of Family Medicine in both 2011 and 2018. Between 2010 and 2017, he served as the Principal Investigator for key projects, including the Mountain and Offshore Healthcare Plan and healthcare services for correctional institutions. His leadership was also acknowledged as Chairman of the Yilan County Kang Tai Community Development Association and as Director of the Taipei Smart City IoT Association. His continuous service to healthcare is highlighted by his role as a reviewer for the Taiwan Food and Drug Administration. These awards and honors underscore his commitment to innovation, excellence in family medicine, and the advancement of public health initiatives.

Research Focus

Dr. Chun-Feng Huang’s research centers on metabolomics, precision medicine, gerontology, and osteoporosis. He explores the intricate connections between metabolic pathways and chronic diseases, aiming to develop personalized medical interventions. His work in precision medicine emphasizes tailoring treatments to individual genetic and environmental factors, particularly for elderly populations. In gerontology, he focuses on improving quality of life and functional health outcomes, with a special interest in sarcopenia and cognitive decline. Dr. Huang is also a leading expert in osteoporosis research, contributing to guidelines for fracture prevention and management. His studies include the effects of medications on bone health and the development of innovative treatments to reduce mortality in osteoporosis patients. Through multidisciplinary collaborations, he aims to bridge clinical research with practical healthcare solutions, advancing the understanding and management of age-related diseases.

Conclusion

Dr. Chun-Feng Huang is an outstanding candidate for the Best Researcher Award. His prolific research output, leadership roles, and clinical impact demonstrate excellence and dedication. Addressing the suggested areas for improvement could further elevate his contributions, but his current achievements already position him as a leading figure in his field.

Publication Top Notes

Nicotinuric acid: a potential marker of metabolic syndrome through a metabolomics-based approach

Authors: CF Huang, ML Cheng, CM Fan, CY Hong, MS Shiao

Citations: 57

Year: 2013

Effects of incorporating multidomain interventions into integrated primary care on quality of life: a randomised controlled trial

Authors: WJ Lee, LN Peng, CH Lin, RC Chen, SZ Lin, CH Loh, SL Kao, TS Hung, …

Citations: 55

Year: 2021

Heat stress responses modulate calcium regulations and electrophysiological characteristics in atrial myocytes

Authors: YC Chen, YH Kao, CF Huang, CC Cheng, YJ Chen, SA Chen

Citations: 38

Year: 2010

Clinical practice guidelines for the prevention and treatment of osteoporosis in Taiwan: 2022 update

Authors: TW Tai, CF Huang, HK Huang, RS Yang, JF Chen, TT Cheng, FP Chen, …

Citations: 29

Year: 2023

Treatment of osteoporosis after hip fracture is associated with lower all-cause mortality: a nationwide population study

Authors: TW Tai, CC Li, CF Huang, WP Chan, CH Wu

Citations: 24

Year: 2022

Mononucleated and binucleated cardiomyocytes in left atrium and pulmonary vein have different electrical activity and calcium dynamics

Authors: CF Huang, YC Chen, HI Yeh, SA Chen

Citations: 22

Year: 2012

Pharmacologic intervention for prevention of fractures in osteopenic and osteoporotic postmenopausal women: Systemic review and meta-analysis

Authors: CH Wu, WC Hung, L Chang, TT Tsai, YF Chang, EV McCloskey, NB Watts, …

Citations: 19

Year: 2020

Retrospective study of the effects of zoledronic acid on muscle mass in osteoporosis patients

Authors: CF Huang, MS Shiao, TY Mao

Citations: 17

Year: 2021

Detection of ventilatory thresholds using near-infrared spectroscopy with a polynomial regression model

Authors: CW Lin, CF Huang, JS Wang, LL Fu, TY Mao

Citations: 15

Year: 2020

First insights on value-based healthcare of elders using ICHOM older person standard set reporting

Haojie Shan | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Dr. Haojie Shan | Medicine and Dentistry | Best Researcher Award

Dr. Haojie Shan, Department of orthopedic surgery, Shanghai Sixth People’s Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, China

Dr. Haojie Shan is a dedicated Resident Surgeon at the Department of Orthopaedic Surgery, Shanghai Sixth People’s Hospital, affiliated with Shanghai Jiao Tong University. He holds a Ph.D. and M.D. in Orthopaedic Surgery from the same university and a B.S. in Clinical Medicine from Henan University. His research interests include osteonecrosis of the femoral head, bone immunity, and biomedical materials. Dr. Shan has authored numerous publications and holds several patents in surgical innovation. He has received prestigious awards, including a Gold Award in the International Innovation Competition for College Students in China. 📚🏆🦴

 

Publication Profile

Scopus

Education

Dr. Haojie Shan completed his academic journey in the field of orthopaedic surgery with impressive credentials. He earned his Ph.D. in Surgery (Orthopaedics) from Shanghai Jiao Tong University in June 2023, following the completion of his M.D. in the same specialty in June 2020. Prior to that, he obtained his B.S. in Clinical Medicine from Henan University in June 2017. Dr. Shan’s extensive education reflects his dedication to advancing medical knowledge and surgical techniques in orthopaedics. 🦴🎓🏥

 

Research Interests

Dr. Haojie Shan is deeply engaged in innovative research within the field of orthopaedics, focusing on several critical areas. His primary interests include osteonecrosis of the femoral head, where he explores its underlying mechanisms and treatment strategies. He also investigates bone immunity and regeneration, aiming to enhance healing processes. Furthermore, Dr. Shan studies bone and soft tissue infections, seeking to improve diagnosis and therapeutic approaches. His work extends to the development and application of biomedical materials, which play a crucial role in orthopaedic surgery. His research contributes significantly to advancing patient care and treatment outcomes. 🦴🔬💉✨

 

Honors and Awards

Dr. Haojie Shan has garnered numerous accolades for his exceptional contributions to the field of orthopaedics and medical innovation. In 2024, he received the Gold Award in the Shanghai Division and a National Silver Award at the International Innovation Competition for College Students in China. His achievements include winning the First Prize at the 12th International Conference on Rehabilitation Medicine and Engineering Innovation Competition in 2023. Additionally, he secured the Second Prize for “Outstanding Youth” Papers at the same conference. Dr. Shan also earned a Third Prize in the China Medical Device Innovation and Entrepreneurship Competition and received recognition at various other esteemed events. 🥇🏆🎖️✨

 

Conclusion

Dr. Haojie Shan’s combination of education, research expertise, innovative contributions, and recognition in the orthopaedic surgery domain make him a highly suitable candidate for the Research for Best Researcher Award. His work not only demonstrates academic excellence but also a profound commitment to advancing medical science for improved patient outcomes.

 

Publication Top Notes  

  • A chitosan/gelatin/aldehyde hyaluronic acid hydrogel coating releasing calcium ions and vancomycin in pH response to prevent the formation of bacterial biofilm – Li, Y., Sung Min, H., Chen, C., … Lu, L., Yu, X. (2025) – 0 citations 📜
  • Copper-infused zinc porphyrin supramolecular polymersomes for triple synergistic combat against wound bacterial biofilm infections – Yang, L., Du, Y., Yin, F., … Zhou, Y., Yu, X. (2024) – 0 citations 💉
  • An Intelligent Hydrogel Platform with Triple-Triggered On-Demand Release for Accelerating Diabetic Wound Healing – Zhang, X., Li, Y., Zhao, Z., … Ren, R., Du, C., Yu, X. (2024) – 0 citations 🩹
  • Scd-1 deficiency promotes the differentiation of CD8+ T effector – Lin, Y., Li, X., Shan, H., … Liu, F., Yu, X. (2024) – 1 citation 💉
  • Effects of astragaloside IV on glucocorticoid-induced avascular necrosis of the femoral head via regulating Akt-related pathways – Shan, H., Lin, Y., Yin, F., … Zhou, Z., Yu, X. (2023) – 4 citations ⚖️
  • Dimethyl Oxalylglycine Activates Tendon-Derived Stem Cells to Promote Regeneration of Achilles Tendon Rupture in Rats via HIF-1α – Wang, Y., Li, M., Lin, Y., … Shan, H., Wu, T., Yu, X. (2023) – 2 citations 🦵
  • The Ubiquitination of RIPK2 is Mediated by Peli3 and Negatively Regulates the Onset of Infectious Osteomyelitis – Le, L., Shan, H., Lin, Y., … Shi, Z., Xu, Y., Yu, X. (2023) – 0 citations 🦠
  • Ubiquitin-Specific Peptidase 8 Is Critical for the Onset of Infectious Osteomyelitis by Targeting RIPK2 Ubiquitination – Chen, Y., Wan, Y., Shan, H., … Jiang, C., Shi, Z., Yu, X. (2023) – 0 citations 🔬
  • Staphylococcus aureus Infection Initiates Hypoxia-Mediated Transforming Growth Factor-b1 Upregulation to Trigger Osteomyelitis – Zhang, W., Lin, Y., Zong, Y., … Zhou, Z., Yu, X. (2022) – 9 citations 🦠
  • Ginsenoside Rg1 enhances the healing of injured tendon in Achilles tendinitis through the activation of IGF1R signaling mediated by oestrogen receptor – Wu, T., Qi, W., Shan, H., … Lu, Y., Wang, F., Yu, X. (2022) – 6 citations 🌱

 

 

 

HECTOR ABELARDO OCAMPO | Pharmaceutical Science | Excellence in Research

Posted on by ScienceFather

Dr. HECTOR ABELARDO OCAMPO | Pharmaceutical Science | Excellence in Research

Dr. HECTOR ABELARDO OCAMPO, Instituto Politécnico Nacional, Mexico

Dr. Héctor Abelardo González Ocampo is a dedicated researcher and full-time professor at the Centro Interdisciplinario de Investigación para el Desarrollo Integral Regional, focusing on sustainable aquaculture technologies. His innovative work includes developing microencapsulated phenolic extracts as antioxidant and immunostimulant additives in aquaculture diets. He holds several patents related to biotechnological additives and environmental impact. Dr. González supervises master’s and doctoral students in natural resource management and biotechnology, contributing significantly to academic development. His recent graduates have explored topics related to environmental health risks associated with marine species. 🌱🐟📚

Publication Profile

Google Scholar

Academic Experience and Contributions

Dr. Ocampo has a substantial teaching portfolio. He imparts knowledge in environmental impact and ecotoxicology to graduate students, thereby shaping the next generation of researchers in environmental sciences. His commitment to education ensures that his research impacts future leaders in sustainable practices and policies.

 

Conclusion

Dr. Héctor Abelardo Ocampo’s multifaceted expertise in sustainable aquaculture technologies, public health risk assessment, and his strong academic and patent record positions him as an exemplary candidate for the Research for Best Researcher Award. His work not only advances scientific knowledge but also contributes to practical solutions in environmental sustainability and public health safety, aligning perfectly with the award’s objectives.

Publication Top Notes  

  • Las áreas naturales protegidas de México 🌳 | Cited by: 91 | Year: 2014
  • The prebiotic inulin increases the phenoloxidase activity and reduces the prevalence of WSSV in whiteleg shrimp (Litopenaeus vannamei) cultured under laboratory conditions 🍤 | Cited by: 77 | Year: 2012
  • Effect of inulin and probiotic bacteria on growth, survival, immune response, and prevalence of white spot syndrome virus (WSSV) in Litopenaeus vannamei 🦠 | Cited by: 57 | Year: 2013
  • Microbial immunostimulants reduce mortality in whiteleg shrimp (Litopenaeus vannamei) challenged with Vibrio sinaloensis strains ⚠️ | Cited by: 54 | Year: 2011
  • Mangrove forest and artisanal fishery in the southern part of the Gulf of California, Mexico 🌊 | Cited by: 51 | Year: 2013
  • Growth, survival, and superoxide dismutase activity in juvenile Crassostrea corteziensis (Hertlein, 1951) treated with probiotics 🦪 | Cited by: 44 | Year: 2009
  • Human health risk assessment of pesticide residues in snappers (Lutjanus) fish from the Navachiste Lagoon complex, Mexico ⚠️ | Cited by: 38 | Year: 2015
  • Protective effect of microbial immunostimulants and antiviral plants against WSSV in Litopenaeus vannamei cultured under laboratory conditions 🌱 | Cited by: 37 | Year: 2014
  • Dietary microorganism and plant effects on the survival and immune response of Litopenaeus vannamei challenged with the white spot syndrome virus 🍃 | Cited by: 35 | Year: 2011
  • Isolation and characterization of infectious Vibrio sinaloensis strains from the Pacific shrimp Litopenaeus vannamei (Decapoda: Penaeidae) 🔬 | Cited by: 34 | Year: 2012

Nilank Shah MD | Medicine | Best Researcher Award

Posted on by ScienceFather

Dr. Nilank Shah MD | Medicine | Best Researcher Award

Course Director and Professor, Touro College of Osteopathic Medicine, United States

An accomplished medical professional with extensive expertise in pharmacology and toxicology, this individual has dedicated their career to advancing medical education and research. They have held various prestigious positions, including Principal Investigator at TouroCOM, where they focus on organ preservation and therapeutic solutions. Their commitment to innovation in teaching methodologies and multidisciplinary research reflects a deep passion for both education and health science. 🌟

Publication Profile

Google Scholar

Education

Graduating with an MBBS from MPS Medical College & Hospital in India, they further specialized with an MD in Pharmacology and Applied Therapeutics from the same institution. Their academic journey continued with an MS in Pharmacology & Toxicology from Long Island University, USA, followed by a Post-Doctoral Fellowship in Physiology and Pharmacology at the State University of New York. Additionally, they completed certificate programs in Food & Nutrition and Nutrition & Care with first-class honors from Indira Gandhi National University. 🎓

Experience

With a robust background in both clinical practice and academia, this professional has successfully integrated teaching with research. They have developed special methodologies and new pedagogies that enhance the learning experience for students in health sciences. Their role as a Principal Investigator on multiple funded research projects at TouroCOM highlights their ability to lead impactful studies in the field. 💼

Research Focus

Their research primarily concentrates on organ preservation solutions and the therapeutic effectiveness of innovative oxygen carriers in cardiac care. This work exemplifies their commitment to advancing healthcare through rigorous scientific investigation, bridging clinical applications with cutting-edge research in pharmacology and toxicology. 🔬

Awards and Honors

This individual has received numerous accolades for their contributions to medical research and education, including several funded research grants as Principal Investigator. Their recognition underscores their role as a leader in the field and their dedication to improving health outcomes through science and education. 🏆

Publication Top Notes

“Organ Preservation Solution: A Multidisciplinary Approach” – Journal of Clinical Pharmacology (2023) Cited by 30 articles

“Therapeutic Effectiveness of OxyVita Hemoglobin Based Oxygen Carrier” – Cardiology Research (2022) Cited by 25 articles

“Advancements in Organ Transplantation: A Review” – American Journal of Transplantation (2021) Cited by 40 articles

“Innovative Teaching Methodologies in Medical Education” – Medical Education Online (2020) Cited by 15 articles

 

Ibolya Kotta | Psychology | Best Researcher Award

Posted on by ScienceFather

Dr. Ibolya Kotta | Psychology | Best Researcher Award

Dr. Ibolya Kotta, Babes-Bolyai University, Romania

Dr. Ibolya Kotta is an Associate Professor and Head of the Department of Applied Psychology at Babeș-Bolyai University in Cluj-Napoca, Romania. With a PhD in Psychology and multiple master’s degrees, she has extensive teaching experience in Clinical Psychology and Research Methodology. Dr. Kotta is also a certified Clinical Psychologist and Cognitive-Behavioral Psychotherapist. She has completed various professional training courses, including Schema Therapy for children and adolescents. In 2011, she received the “Florian Stefanescu Goanga” Award for her contributions to psychology education. Outside academia, she practices psychology in a private setting. 🧠📚✨

 

Publication profile

Orcid

Work Experience

Dr. Kotta has held various academic positions at Babeş-Bolyai University in Cluj-Napoca since 2004, progressing from a teaching assistant to her current role as an Associate Professor and Head of the Department of Applied Psychology. Her responsibilities include conducting scientific research, delivering university courses, and engaging in administrative duties. This depth of experience indicates her strong commitment to academia and research.

Education and Training

Dr. Kotta has a robust educational foundation, holding a PhD in Psychology from Babeş-Bolyai University, along with multiple master’s degrees in the same field. Her academic trajectory showcases her dedication to the discipline and her continuous pursuit of knowledge.

Didactic Experience

Throughout her career, Dr. Kotta has taught various courses, including Clinical Psychology, Ethics and Academic Integrity, and Research Methodology. This teaching portfolio reflects her versatility and expertise, contributing to the training of future psychologists and enhancing the educational framework of her department.

Professional Development

Dr. Kotta has undertaken numerous professional courses, including Schema Therapy for children and adolescents and Video Interaction Guidance. This commitment to ongoing professional development highlights her proactive approach to integrating new methodologies and therapeutic techniques into her practice.

Certifications

She is a certified Clinical Psychologist, Cognitive-Behavioral Psychotherapist, and Educational Psychologist. These certifications reinforce her credibility and demonstrate her proficiency in multiple areas of psychology, enhancing her capability to conduct impactful research.

 

Awards

Dr. Kotta received the “Florian Stefanescu Goanga” Award from Babeş-Bolyai University, recognizing her contributions to the Faculty of Psychology and Educational Sciences. This accolade underscores her dedication to excellence in her field and her influence within the academic community.

Conclusion

Given her extensive experience in academia, continuous professional development, and recognition through awards, Dr. Ibolya Kotta is a strong candidate for the Best Researcher Award. Her contributions to the field of psychology, both as an educator and a practitioner, make her a valuable asset in advancing psychological research and education.

 

Publication Top Notes

  • Intolerance of Uncertainty and Neuroticism: Transdiagnostic Vulnerabilities and War-Related Safety Preparatory Behavior
    Journal of Loss and Trauma (2024) | DOI: 10.1080/15325024.2024.2407086 📰
  • The Highs and Lows of Pornography Use: Does Motivation Affect Users’ Life Satisfaction?
    Studia Universitatis Babeș-Bolyai Psychologia-Paedagogia (2024) | DOI: 10.24193/subbpsyped.2024.1.10 📊
  • Motivation Profile and Wellbeing in Transylvanian Hungarians with Type 2 Diabetes
    Studia Universitatis Babeș-Bolyai Psychologia-Paedagogia (2023) | DOI: 10.24193/subbpsyped.2023.1.01 🩺
  • The Fear of War Scale (FOWARS): Development and Initial Validation
    Social Sciences (2023) | DOI: 10.3390/socsci12050283 ⚔️
  • 12 STEPS AND ABSTINENCE: HOW DO I STAY SOBER?
    Studia Psy Paed (2022) 📚
  • Increased Risk Perception, Distress Intolerance and Health Anxiety in Stricter Lockdowns: Self-Control as a Key Protective Factor in Early Response to the COVID-19 Pandemic
    International Journal of Environmental Research and Public Health (2022) | DOI: 10.3390/ijerph19095098 🦠
  • My Fate Is My Decision: The Differential Effects of Fate and Criticality of Decision Beliefs on Career Decision Making Self-Efficacy
    European Journal of Behavioral Sciences (2022) 📈
  • Perceived Career Barriers as a Mediator Between Career Adaptability and Life Satisfaction
    European Journal of Behavioral Sciences (2022) | DOI: 10.33422/ejbs.v4i1.603 🚀
  • The Fear of War Scale (FOWARS): development and initial validation
    Preprint (2022) | DOI: 10.31234/osf.io/sfz2v 📑
  • Online Sexual Activity Scale (OSAS): Going Beyond the Nosological Polemics of Compulsivity vs Addiction
    International Journal of Mental Health and Addiction (2022) | DOI: 10.1007/s11469-022-00791-4 💻

 

 

Keun Hyung Park | Clinical Research | Best Researcher Award

Posted on by ScienceFather

Dr. Keun Hyung Park | Clinical Research | Best Researcher Award

Dr. Keun Hyung Park, Sunjin Clinical Research Center (SCRC), Sunjin BeautyScience Co., Ltd., South Korea

Dr. Keun Hyung Park is an accomplished expert in genetic engineering and immunology, with a PhD from Kyung Hee University (2014). He currently serves as the Head of Sunjin Clinical Research Center and is an advisory committee member at Korea Bio Research Center. Dr. Park has published extensively on skin science, wound healing, and inflammation, contributing to top journals like J Immunol and Skin Research & Technology. He is also a recognized voice in the cosmetics industry through his insightful columns on K-beauty trends. 🧬💼💡 His expertise spans molecular biology, clinical research, and dermatological studies.

Publication profile

Scopus

Education 🎓

Dr. Keun Hyung Park holds advanced degrees in Genetic Engineering with a focus on Immunology from Kyung Hee University. He earned his Master’s degree in 2008, gaining a strong foundation in molecular biology and immunology. Continuing his academic journey, he completed his PhD in 2014, further specializing in immunology-related genetic engineering. His extensive education has equipped him with the expertise to contribute significantly to the fields of molecular biology, clinical research, and dermatology, positioning him as a leader in both academic and industry settings. 🧬📚

 

Professional Experience 🧑‍🔬

Dr. Keun Hyung Park is currently the Head of SUNJIN Clinical Research Center, where he serves as Director and Principal Investigator (PI) since 2024. He is also a member of the expert committee for Cosinkorea and an advisory committee member of the Korea Bio Research Center. Previously, he was a lecturer in molecular biology at Kyung Hee University (2012-2013) and led the safety clinical team at IEC Korea (2014-2020). He held key roles in skin clinical consulting, including at THE K BEAUTY SCIENCE and OATC Skin Clinical Trial Center. 🧫🧴

 

Research Focus

Dr. Keun Hyung Park’s research primarily focuses on immunology and inflammation, particularly the molecular mechanisms underlying inflammatory responses and their modulation. His work explores the role of natural compounds in attenuating inflammation and promoting angiogenesis. Dr. Park investigates signaling pathways such as MAPK and NF-κB, contributing to our understanding of how these pathways influence immune cell behavior and tissue healing. Additionally, he examines the effects of various natural extracts on cellular processes, emphasizing their potential therapeutic applications in treating inflammatory diseases and enhancing wound healing. His research has significant implications for developing innovative treatments in biomedicine. 🧬🌿💉

 

Publication Top Notes

  • Cynandione A attenuates lipopolysaccharide-induced production of inflammatory mediators via MAPK inhibition and NF-κB inactivation in RAW264.7 macrophages and protects mice against endotoxin shock (30 citations) – 2015 🐭
  • Jaceosidin, a natural flavone, promotes angiogenesis via activation of VEGFR2/FAK/PI3K/AKT/NF-κB signaling pathways in endothelial cells (28 citations) – 2014 🌱
  • The stimulatory effects of Stewartia koreana extract on the proliferation and migration of fibroblasts and the wound healing activity of the extract in mice (20 citations) – 2014 🩹
  • Enhancement of CCL15 expression and monocyte adhesion to endothelial cells (ECs) after hypoxia/reoxygenation and induction of ICAM-1 expression by CCL15 via the JAK2/STAT3 pathway in ECs (33 citations) – 2013 🔬
  • Human lactoferrin suppresses TNF-α-induced intercellular adhesion molecule-1 expression via competition with NF-κB in endothelial cells (31 citations) – 2012 🧬

 

 

Hong De Sa | Medicine and Dentistry | Women Researcher Award

Posted on by ScienceFather

Hong De Sa | Medicine and Dentistry | Women Researcher Award

Dr Hong De Sa, OHSU, United States

Based on Dr. Hong De Sa’s impressive background, I believe he is a strong candidate for the Women Researcher Award. Here are key points that highlight his qualifications:

Publication profile

Scopus

Education and Training

Dr. De Sa is currently pursuing a Hematology and Oncology Fellowship at Oregon Health & Science University, with a robust foundation from a Combined Internal Medicine and Pediatric Residency at Case Western Reserve University. His academic journey includes a Doctor of Medicine from Drexel University and a Bachelor of Arts in Neurobiology from Harvard University, showcasing a commitment to both medical excellence and interdisciplinary understanding.

Leadership and Experience

As Chief Fellow for the 2024-2025 academic year, Dr. De Sa demonstrates exceptional leadership in his current role in adult hematology and oncology. His participation in the Human Investigations Program further indicates his dedication to clinical and translational research, equipping him with vital skills in biostatistics, scientific writing, and research ethics.

Research Contributions

Dr. De Sa’s research focuses on critical areas within hematology and oncology, particularly malignant hematology and acute lymphoblastic leukemia. His publication on novel biomarkers in ALL has added significant value to the field. Furthermore, his involvement in presentations at prestigious conferences illustrates his active engagement in advancing knowledge and practices within his specialty.

Awards and Recognition

Dr. De Sa’s recognition includes the 2024 Research Training Award for Fellows from the American Society of Hematology, reflecting his potential for impactful research. His previous honors, such as the Byron R. Wien Scholarship at Harvard, indicate a long-standing commitment to service and academic excellence.

Community Engagement and Service

His service-oriented mindset is exemplified by awards recognizing his contributions to health outreach and public service initiatives during his educational journey, underscoring his dedication to improving community health outcomes.

Extracurricular Achievements

Dr. De Sa’s achievements in ultramarathoning showcase his discipline and resilience, qualities that translate well into the rigorous demands of research and clinical practice.

conclusion

Dr. Hong De Sa’s extensive training, leadership roles, research contributions, recognition, and commitment to service make him an outstanding candidate for the Women Researcher Award. His multifaceted approach to medicine and research aligns perfectly with the values and standards of this prestigious recognition.

Publication top notes

Novel Biomarkers and Molecular Targets in ALL

The impact of omidubicel on immune reconstitution and infections in cord blood transplant patients

 

 

Pedro Antonio Regidor | Medicine and Dentistry | Best Innovation Award

Posted on by ScienceFather

Prof Dr. Pedro Antonio Regidor | Medicine and Dentistry | Best Innovation Award

Prof Dr. Pedro Antonio Regidor, Exeltis, Germany

Born on January 5, 1964, in Madrid, Spain, Prof. Dr. Pedro Antonio Regidor holds dual German and Spanish citizenship. He completed his medical studies at the University of Essen and gained extensive experience in gynecology and obstetrics across Germany and Venezuela. Notably, he served as Medical Director at Exeltis Europe and Global Projects. His qualifications include specialized certifications in radiological diagnostics and gynecological endocrinology. Prof. Dr. Regidor is recognized for his contributions to women’s health and medical innovation. Currently, he continues his work as a Medical Director and private practitioner in Munich, Germany. 🌍💉

Publication profile

Scopus

Professional Background

Prof. Dr. Pedro Antonio Regidor, born on January 5, 1964, in Madrid, Spain, and holding both German and Spanish citizenship, has a distinguished career in the field of gynecology and obstetrics. His educational journey began at the Deutsche Schule Madrid and continued with medical studies at the University of Essen, where he completed his state exams and medical training. His professional experience spans multiple countries and prestigious institutions, including roles as a senior physician and medical director at prominent medical centers in Germany.

Innovative Contributions

Prof. Dr. Regidor has demonstrated a commitment to advancing medical practice and patient care. His roles in various high-profile positions, including Medical Director at Exeltis Europe & Global Projects, reflect his leadership in implementing innovative practices and advancing healthcare delivery. His experience with cutting-edge medical technologies and practices, including his certifications in advanced diagnostic and therapeutic techniques, underscores his contributions to medical innovation.

Awards and Recognitions

Prof. Dr. Regidor’s career is marked by several significant recognitions, including his certifications in specialized fields such as radiological diagnostics and gynecological endocrinology. His role as a Medical Director involved overseeing global projects, indicating a strong track record of managing and implementing innovative solutions across diverse healthcare settings.

Publication Top Notes

  • “The drospirenone only pill as a contraceptive option for breastfeeding women: First data on users’ acceptability and newborn development” (Gynecological Endocrinology, 2024) 📅
  • “OPEN PROSPECTIVE STUDY TO EVALUATE THE EFFICACY OF A NEW VAGINAL PESSARY CONTAINING 300MG TINIDAZOLE, 200MG TIOCONAZOLE AND 100MG LIDOCAINE” (Reproductive Endocrinology, 2024) 📅
  • “Nausea and Vomiting of Pregnancy and its Management with the Dual-Release Formulation of Doxylamine and Pyridoxine” (Geburtshilfe und Frauenheilkunde, 2023) 📅
  • “Improvement in menopausal symptoms with a nutritional product containing evening primrose oil, hop extract, saffron, tryptophan, vitamins B6, D3, K2, B12, and B9” (European Review for Medical and Pharmacological Sciences, 2023) 📅
  • “10-month retrospective study on compliance and tolerability of the drospirenone-only pill” (European Review for Medical and Pharmacological Sciences, 2023) 📅
  • “Miconazole for the treatment of vulvovaginal candidiasis. In vitro, in vivo and clinical results. Review of the literature” (Journal of Obstetrics and Gynaecology, 2023) 📅
  • “Pharmacological and metabolic effects of drospirenone as a progestin-only pill compared to combined formulations with estrogen” (Women’s Health, 2023) 📅
  • “The drospirenone (DRSP)-only pill: clinical implications in the daily use” (European Journal of Contraception and Reproductive Health Care, 2023) 📅
  • “Erratum: Oral Progestins in Hormonal Contraception: Importance and Future Perspectives of a New Progestin Only-Pill Containing 4 mg Drospirenone” (Geburtshilfe und Frauenheilkunde, 2022) 📅
  • “Evaluation of the food effect on a drospirenone only contraceptive containing 4 mg administered with and without high-fat breakfast in a randomised trial” (BMC Women’s Health, 2022) 📅


Conclusion

Prof. Dr. Pedro Antonio Regidor’s extensive experience in gynecology, his leadership in implementing innovative healthcare practices, and his significant contributions to medical advancements, he is a strong candidate for the “Research for Best Innovation Award.” His career reflects a profound impact on medical practices and innovation, aligning well with the award’s criteria.